EdwardVincentMaytinMDPhD

Dermatology • Cleveland, OH

Physician

Join to view full profile

Dr. Maytin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maytin's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 216-444-2200

Fax+1 216-444-9198

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1986 - 1990
Brown UniversityInternship, Internal Medicine, 1985 - 1986
University of Rochester School of Medicine and DentistryClass of 1985

Certifications & Licensure

CA State Medical License 1990 - Present
OH State Medical License 2000 - 2026
MA State Medical License 1990 - 2011
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer Start of enrollment: 2008 Mar 01
Terminated
Early Phase 1
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses Start of enrollment: 2014 Apr 01
Completed
Phase 3
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Start of enrollment: 2016 Feb 01
Completed
Not Applicable
Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome Start of enrollment: 2014 Dec 01
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma Start of enrollment: 2018 Oct 01
Active, not recruiting
Phase 1
Biomarker Database Registry for Photodynamic Therapy Start of enrollment: 2017 Oct 06
Completed
Roles: Contact, Principal Investigator
Vitamin D and Photodynamic Therapy for Treatment of BCC in BCNS Start of enrollment: 2018 Oct 01
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy Start of enrollment: 2021 Dec 13
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses Start of enrollment: 2023 Oct 02
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses Start of enrollment: 2024 Oct 01
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

17 citations
Heparin inhibits proinflammatory and promotes anti-inflammatory macrophage polarization under hyperglycemic stress
Amina Abbadi, Jacqueline Loftis, Aimin Wang, Minjia Yu, Yan Wang
The Journal of Biological Chemistry. 2020-02-27
36 citations
Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of a...
Stephen C. Kanick, Scott C. Davis, Yan Zhao, Tayyaba Hasan, Edward V. Maytin
Journal of Biomedical Optics. 2014-07-01
69 citations
Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy
Sanjay Anand, Clara Wilson, Tayyaba Hasan, Edward V. Maytin
Cancer Research. 2011-09-15

Lectures

Innovations & Multidisciplinary Perspectives in Cosmetic Surgery
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Fort Lauderdale, Florida - 3/23/2012

Press Mentions

Dermatologists Combine Two Effective Treatments for Precancerous Actinic KeratosesSeptember 13th, 2018
Expanding Our Options for Treating Actinic KeratosesJanuary 26th, 2021

Grant Support

Small Molecule Enhancers Of Photodynamic Therapy For Skin CancerNational Cancer Institute2009–2012
Hyaluronan (HA) As A Regulator Of Inflammation And FibrosisNational Heart, Lung, And Blood Institute2011
Combination Therapy With 5-FU And PDT For The Treatment Of Post-Transplant PremalNational Cancer Institute2011
Hyaluronan In Epidermal Injury ResponsesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009
Hyaluronan And Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2007
Role Of Cellular DifferentiationNational Cancer Institute2001–2002
C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–1999
Regulation Of The K10 Gene By C/Ebps In KeratinocytesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1997

EdwardVincentMaytinMDPhD

Dr. Maytin is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.